219 related articles for article (PubMed ID: 27993908)
1. Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.
Golwala H; Bajaj NS; Arora G; Arora P
Circulation; 2017 Jan; 135(2):201-203. PubMed ID: 27993908
[No Abstract] [Full Text] [Related]
2. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
Akel T; Lafferty J
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
[TBL] [Abstract][Full Text] [Related]
3. Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy.
Cavalcanti R; Aboul-Hosn N; Morales G; Abdel-Latif A
Angiology; 2018 Apr; 69(4):297-302. PubMed ID: 28554215
[TBL] [Abstract][Full Text] [Related]
4. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.
Al-Khatib SM; Fonarow GC; Joglar JA; Inoue LYT; Mark DB; Lee KL; Kadish A; Bardy G; Sanders GD
JAMA Cardiol; 2017 Jun; 2(6):685-688. PubMed ID: 28355432
[TBL] [Abstract][Full Text] [Related]
5. Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Luni FK; Singh H; Khan AR; Malik SA; Khawaja O; Riaz H; Lee W; Kabour A; Richards M; Aasbo J
J Cardiovasc Electrophysiol; 2017 May; 28(5):538-543. PubMed ID: 28370885
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
[TBL] [Abstract][Full Text] [Related]
7. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.
Beggs SAS; Jhund PS; Jackson CE; McMurray JJV; Gardner RS
Heart; 2018 Jan; 104(2):144-150. PubMed ID: 28986406
[TBL] [Abstract][Full Text] [Related]
8. Letter by Nery et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
Nery PB; Lewis KB; Birnie DH
Circulation; 2017 Jun; 135(25):e1198-e1199. PubMed ID: 28630274
[No Abstract] [Full Text] [Related]
9. Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
Barakat AF; Saad M; Elgendy IY
Circulation; 2017 Jun; 135(25):e1196-e1197. PubMed ID: 28630273
[No Abstract] [Full Text] [Related]
10. Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
Golwala H; Bajaj NS; Arora G; Arora P
Circulation; 2017 Jun; 135(25):e1200-e1202. PubMed ID: 28630275
[No Abstract] [Full Text] [Related]
11. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Warner Stevenson L; Varosy PD; Welikovitch L
Heart Rhythm; 2014 Jul; 11(7):1271-303. PubMed ID: 24819194
[No Abstract] [Full Text] [Related]
12. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
[TBL] [Abstract][Full Text] [Related]
13. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
Desai AS; Fang JC; Maisel WH; Baughman KL
JAMA; 2004 Dec; 292(23):2874-9. PubMed ID: 15598919
[TBL] [Abstract][Full Text] [Related]
14. Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials.
Barakat AF; Saad M; Elgendy AY; Mentias A; Abuzaid A; Mahmoud AN; Elgendy IY
BMJ Open; 2017 Jun; 7(6):e016352. PubMed ID: 28637742
[TBL] [Abstract][Full Text] [Related]
15. Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials.
Romero J; Chaudhary R; Garg J; Lupercio F; Shah N; Gupta R; Nazir T; Bozorgnia B; Natale A; Di Biase L
J Interv Card Electrophysiol; 2017 Sep; 49(3):263-270. PubMed ID: 28674918
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator Recipients.
Escande W; Boveda S; Defaye P; Leclercq C; Sadoul N; Perier MC; Deharo JC; Fauchier L; Marijon E; Piot O;
J Am Coll Cardiol; 2017 Sep; 70(10):1302-1303. PubMed ID: 28859794
[No Abstract] [Full Text] [Related]
17. Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice.
Boveda S; Narayanan K; Jacob S; Providencia R; Algalarrondo V; Bouzeman A; Beganton F; Defaye P; Perier MC; Sadoul N; Piot O; Klug D; Gras D; Fauchier L; Bordachar P; Babuty D; Deharo JC; Leclercq C; Marijon E;
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):666-673. PubMed ID: 28251724
[TBL] [Abstract][Full Text] [Related]
18. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.
Wolff G; Lin Y; Karathanos A; Brockmeyer M; Wolters S; Nowak B; Fürnkranz A; Makimoto H; Kelm M; Schulze V
Clin Res Cardiol; 2017 Jul; 106(7):501-513. PubMed ID: 28213711
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention implantable cardioverter defibrillators in non-ischaemic cardiomyopathy: challenging the Australian heart failure guidelines.
Lau DH; Kalman JM; Sanders P
Med J Aust; 2019 Aug; 211(4):154-155.e1. PubMed ID: 31216054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
